Expression and significance of CHIP in canine mammary gland tumors

CHIP (Carboxy terminus of Hsc70 Interacting Protein) is an E3 ubiquitin ligase that can induce ubiquitination and degradation of several oncogenic proteins. The expression of CHIP is frequently lower in human breast cancer than in normal breast tissue. However, the expression and role of CHIP in the canine mammary gland tumor (CMGT) remain unclear. We investigated the potential correlation between CHIP expression and mammary gland tumor prognosis in female dogs. CHIP expression was measured in 54 dogs by immunohistochemistry and real-time RT-PCR. CHIP protein expression was significantly correlated with the histopathological diagnosis, outcome of disease and tumor classification. The transcriptional level of CHIP was significantly higher in normal tissues (P=0.001) and benign tumors (P=0.009) than it in malignant tumors. CHIP protein expression was significantly correlated with the transcriptional level of CHIP (P=0.0102). The log-rank test survival curves indicated that patients with low expression of CHIP had shorter overall periods of survival than those with higher CHIP protein expression (P=0.050). Our data suggest that CHIP may play an important role in the formation and development of CMGTs and serve as a valuable prognostic marker and potential target for genetic therapy.

[1]  Baoliang Li,et al.  Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma , 2014, Tumor Biology.

[2]  J. Javanbakht,et al.  Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an Clinico-Cytohistopathological study with environmental factors influencing public health and medicine , 2013, Cancer Cell International.

[3]  Gang Li,et al.  CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer , 2012, Gut.

[4]  M. Mochizuki,et al.  Relationship between NF-κB expression and malignancy of canine mammary gland tumor tissues. , 2012, The Journal of veterinary medical science.

[5]  M. Hung,et al.  Tid1, CHIP and ErbB2 interactions and their prognostic implications for breast cancer patients , 2011, The Journal of pathology.

[6]  K. Song,et al.  The C-terminus of Hsp70-Interacting Protein Promotes Met Receptor Degradation , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  V. Zappulli,et al.  Classification and Grading of Canine Mammary Tumors , 2011, Veterinary pathology.

[8]  R. Fernandes,et al.  The Chaperone-Dependent Ubiquitin Ligase CHIP Targets HIF-1α for Degradation in the Presence of Methylglyoxal , 2010, PloS one.

[9]  W. Jiang,et al.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer , 2010, Journal of carcinogenesis.

[10]  H. Xin,et al.  CHIP functions an E3 ubiquitin ligase of Runx1. , 2009, Biochemical and biophysical research communications.

[11]  M. Kurosumi,et al.  The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways , 2009, Nature Cell Biology.

[12]  D. Lane,et al.  Chaperone-dependent stabilization and degradation of p53 mutants , 2008, Oncogene.

[13]  C. Qiu,et al.  Expression and significance of PTEN and VEGF in canine mammary gland tumours , 2008, Veterinary Research Communications.

[14]  G. Blandino,et al.  Mutant p53: an oncogenic transcription factor , 2007, Oncogene.

[15]  D. Manor,et al.  Regulation of Proto-Oncogenic Dbl by Chaperone-Controlled, Ubiquitin-Mediated Degradation , 2006, Molecular and Cellular Biology.

[16]  J. Sirois,et al.  Cyclooxygenase-2 Expression in Normal and Neoplastic Canine Mammary Cell Lines , 2006, Veterinary pathology.

[17]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[18]  K. Nephew,et al.  CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. , 2005, Molecular endocrinology.

[19]  T. Constantinidis,et al.  Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. , 2005, Journal of comparative pathology.

[20]  Xin-Yuan Fu,et al.  CHIP Controls the Sensitivity of Transforming Growth Factor-β Signaling by Modulating the Basal Level of Smad3 through Ubiquitin-mediated Degradation* , 2005, Journal of Biological Chemistry.

[21]  S. Alberti,et al.  Cooperation of molecular chaperones with the ubiquitin/proteasome system. , 2004, Biochimica et biophysica acta.

[22]  P. Robinson,et al.  Ubiquitin-protein ligases , 2004, Journal of Cell Science.

[23]  H. Kim,et al.  Relationship between Urokinase-Type Plasminogen Receptor, Interleukin-8 Gene Expression and Clinicopathological Features in Gastric Cancer , 2004, Oncology.

[24]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[25]  R. Jain,et al.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis , 2004, Nature.

[26]  Chung-Ho Lee,et al.  Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. , 2004, Journal of veterinary science.

[27]  S. Hilsenbeck,et al.  Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. , 2003, Journal of the National Cancer Institute.

[28]  L. Neckers,et al.  Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[30]  D. Neal,et al.  Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer , 2001, British Journal of Cancer.

[31]  D. Cyr,et al.  CHIP Is a U-box-dependent E3 Ubiquitin Ligase , 2001, The Journal of Biological Chemistry.

[32]  D. Schadendorf,et al.  Expression of interleukin‐8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma , 1999, The Journal of pathology.

[33]  A. C. Lee,et al.  Classification and Behavior of Canine Mammary Epithelial Neoplasms Based on Life-span Observations in Beagles , 1999, Veterinary pathology.

[34]  P. Connell,et al.  Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions , 1999, Molecular and Cellular Biology.

[35]  P. Meltzer,et al.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.

[36]  R. Azizkhan,et al.  Characterization of GRO α, β and γ expression in human colonic tumours: potential significance of cytokine involvement , 1992 .

[37]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[38]  Owen Ln.  A comparative study of canine and human breast cancer. , 1979 .

[39]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[40]  P. Connell,et al.  The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins , 2000, Nature Cell Biology.

[41]  R. Azizkhan,et al.  Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement. , 1992, Surgical oncology.

[42]  W. Priester.  Occurrence of mammary neoplasms in bitches in relation to breed, age, tumour type, and geographical region from which reported. , 1979, The Journal of small animal practice.

[43]  L. Owen.  A comparative study of canine and human breast cancer. , 1979, Investigative & cell pathology.